Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity Source: Eur Respir J 2015; 46: 1589-1597 Year: 2015
Small airways disease evaluation in healthy smokers with normal spirometry values Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019
Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS Source: Eur Respir J, 54 (4) 1802214; 10.1183/13993003.02214-2018 Year: 2019
Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020
Correlations between lung function, exhaled carbon monoxide and „lung age” in smokers versus former smokers with COPD Source: International Congress 2017 – Smoking and health hazards Year: 2017
Clinical consideration and lung function in different groups of COPD patients (smokers, ex-smokers, nonsmokers) Source: International Congress 2017 – Smoking and health hazards Year: 2017
Implications of DLCO corrected by hemoglobin concentration for lung function preoperator risk evaluation in obese and non obese stable COPD patients Source: Annual Congress 2007 - Quality, sleep and exercise - the ingredients for a perfect life! Year: 2007
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004
COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function Source: Annual Congress 2009 - Functional insights into COPD Year: 2009
Biomarkers to predict FEV1 decline in smokers and early-onset COPD. Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020
Accuracy for DLco impairment through ventilatory efficiency indices in smokers without COPD. Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021
Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020
Lung function parameters in healthy young smokers and nonsmokers – do they reach their maximal values? Source: International Congress 2018 – Effect of tobacco use on health Year: 2018
Exercise capacity and gas exchange in smokers with discordant GOLD vs FEV1/FVC lower limit of normal (LLN) airway obstruction diagnosis. Source: International Congress 2019 – Cardiopulmonary exercise testing Year: 2019
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Regional lung function in nonsmokers and asymptomatic current and former smokers Source: ERJ Open Res, 5 (3) 00240-2018; 10.1183/23120541.00240-2018 Year: 2019
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Prevalence of abnormal lung volumes, DLCO and chest HRCT in smokers with normal spirometry Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013